Create a free account to see ACCE Scores
Sign up for free to unlock scores, score breakdowns, and stock analysis.
BGM
↓ PDF (Pro)BGM Group Ltd. Class A Ordinary Shares
HealthcareDrug Manufacturers - Specialty & GenericChinaNASDAQ
$0.30
+1.73%today
MKT CAP
$60M
-9.1% · 1Y
Full Financials
Trailing P/E-
Forward P/E-
EV/EBITDA-
Price/Sales-
Dividend Yield-
Revenue Growth YoY-
Earnings Growth YoY-
Revenue Growth QoQ-
5y Revenue CAGR-
5y Earnings CAGR-
Gross Margin-
Operating Margin-
Net Margin-
ROE-
Debt / Equity-
Free Cash Flow-
Insider Ownership63.7%
Institutional Ownership0.2%
Short % of Float0.04%
Days to Cover0.1d
1 Week-6.1%
1 Month-
3 Months-
6 Months-
YTD-
1 Year-
3 Years-
5 Years-
vs 50-day SMA-
vs 200-day SMA-
vs 52w High-
vs 52w Low-
Top Holders
| Holder | Type | % Held | Value | Δ Shares | As of |
|---|---|---|---|---|---|
| Invesco Ltd. | institution | 0.37% | $0.00B | -18.66% | 2025-12-31 |
| State Street Corporation | institution | 0.14% | $0.00B | +4.78% | 2025-12-31 |
| Geode Capital Management, LLC | institution | 0.13% | $0.00B | +4.22% | 2025-12-31 |
| SPDR INDEX SHARES Fd.S-State Street SPDR S&P Emerging Markets Small Ca | fund | 0.12% | $0.00B | -1.91% | 2026-03-31 |
| Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund | fund | 0.07% | $0.00B | +0.00% | 2026-02-28 |
| Fidelity Commonwealth Trust-Fidelity Nasdaq Composite Index ETF | fund | 0.06% | $0.00B | +0.15% | 2026-03-31 |
| UBS Group AG | institution | 0.01% | $0.00B | -60.70% | 2025-12-31 |
| SPDR INDEX SHARES FUNDS-State Street SPDR S&P China ETF | fund | 0.01% | $0.00B | +0.00% | 2026-03-31 |
| JPMORGAN CHASE & CO | institution | 0.00% | $0.00B | +100.00% | 2025-12-31 |
| Tower Research Capital LLC (TRC) | institution | 0.00% | $0.00B | +100.00% | 2025-12-31 |
| Bank of America Corporation | institution | 0.00% | $0.00B | +100.00% | 2025-12-31 |
| Royal Bank of Canada | institution | 0.00% | $0.00B | +100.00% | 2025-12-31 |
| SBI Securities Co., Ltd. | institution | 0.00% | $0.00B | +100.00% | 2026-03-31 |
| Ticker | Cap | Score | P/E | Fwd P/E | EV/EBITDA | ROE | Gross | D/E | Div |
|---|---|---|---|---|---|---|---|---|---|
| BIOA | $820M | - | - | - | - | -27.1% | 0% | 2.04 | 0.00% |
| ETON | $833M | 60 | - | 16.4 | - | - | - | - | 0.00% |
| PCRX | $937M | 58 | 193.0 | 7.0 | - | - | - | - | 0.00% |
| CRON | $990M | 5 | - | - | - | - | - | - | 0.00% |
| AMPH | $1.1B | 100 | 11.8 | 6.9 | - | - | - | - | 0.00% |
| XERS | $1.1B | 60 | 94.7 | 17.0 | - | - | - | - | 0.00% |
Peers selected by sector + industry + nearest market cap. Best in column highlighted green, worst red.
Unlock Full Financials
Growth metrics, valuation multiples, and profitability ratios on Starter+.
Recent Alerts
No alerts yet for BGM.
Want deep analysis?
This stock isn't in the ACCE researched universe. Browse 300+ stocks with full thesis, scores, and financial models.
Browse ACCE Indices →Get the ACCE weekly digest
Index returns, picks recap, score movers - every Sunday. No fluff.